The Effect of Caspase 8, 9 Gene Polymorphisms on Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2022 Dec 29

PMID 36580018

Authors

Fatemeh Barati

Gholamreza Bahari

Anoosha Asadi

Alireza Nakhaee

Seyed-Mehdi Hashemi

Mohsen Taheri

Mohammad Hashemi

Affiliations

Soon will be listed here.

Abstract

Background: Caspases (CASPs) are the main executors of the apoptotic process. Studies to date have shown the role of caspase-8 (CASP8) and caspase-9 (CASP9) in carcinogenesis. Therefore, the aim of this study was to investigate the associations between CASP9-rs4233532, CASP9-rs4646018, and CASP8- rs1045485 gene polymorphisms and non-Hodgkin lymphoma (NHL) susceptibility in an Iranian population-based study. Moreover, it was examined whether such the genotype of these polymorphisms is related with clinicopathological characteristics of NHL.

Methods: 175 patients with NHL and 175 age- and sex-matched controls were enrolled in this study. We determined the genotypes of single nucleotide polymorphisms (SNPs) from CASP genes with Tetra ARMS-PCR (Amplification refractory mutation system) method.

Results: Statistically significant association were observed between CASP9-rs4646018 and increased risk of NHL under codominant CC, codominant TC, and dominant TC+CC genetic models. Our results showed that the A allele of CASP8-rs1045485 was a protective factor for NHL and GArs1045485 genotype significantly reduced risk of NHL. In contrast, CASP9- rs4233532 was not linked to NHL susceptibility. No relationship was detected between CASP8-rs1045485 and CASP9-rs4233532 and NHL clinicopathological characteristics, however genetic variation in CASP9-rs4646018 was associated with histology, treatment and radio therapy of NHL.

Conclusions: Our study presented that the CASP8- rs1045485 and CASP9-rs4646018 polymorphisms could affect the risk of NHL in Iranian populations which was the first report to show the significant relationship between rs1045485, rs4646018 polymorphisms and NHL susceptibility. Replication large-scale case-control studies in different ethnicities are warranted to verify these findings.

References

Sargazi S, Kooshkaki O, Zavar Reza J, Saravani R, Zarei Jaliani H, Mirinejad S . Mild antagonistic effect of Valproic acid in combination with AZD2461 in MCF-7 breast cancer cells. Med J Islam Repub Iran. 2019; 33:29. PMC: 6662678. DOI: 10.34171/mjiri.33.29. View

Yao X, Hao S, Yu P . Association Study of the Caspase Gene Family and Psoriasis Vulgaris Susceptibility in Northeastern China. Biomed Res Int. 2019; 2019:2417612. PMC: 6398065. DOI: 10.1155/2019/2417612. View

Kelly J, Novak A, Fredericksen Z, Liebow M, Ansell S, Dogan A . Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2010; 19(11):2847-58. PMC: 2976783. DOI: 10.1158/1055-9965.EPI-10-0581. View

Wiman K, Zhivotovsky B . Understanding cell cycle and cell death regulation provides novel weapons against human diseases. J Intern Med. 2017; 281(5):483-495. DOI: 10.1111/joim.12609. View

Lan Q, Morton L, Armstrong B, Hartge P, Menashe I, Zheng T . Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood. 2009; 114(2):264-7. PMC: 2714202. DOI: 10.1182/blood-2009-01-198697. View

Shin M, Kim H, Kang C, Park W, Kim S, Lee S . Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood. 2002; 99(11):4094-9. DOI: 10.1182/blood.v99.11.4094. View

Su Z, Yang Z, Xu Y, Chen Y, Yu Q . Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015; 14:48. PMC: 4343053. DOI: 10.1186/s12943-015-0321-5. View

Liu Q, Li X, Song M, Ran R, Wu Z, Yang B . Association between C-myc and K-ras gene polymorphisms and non-Hodgkin lymphoma. Eur Rev Med Pharmacol Sci. 2020; 24(8):4396-4403. DOI: 10.26355/eurrev_202004_21021. View

Teimoori B, Moradi-Shahrebabak M, Razavi M, Rezaei M, Harati-Sadegh M, Salimi S . The effect of GPx-1 rs1050450 and MnSOD rs4880 polymorphisms on PE susceptibility: a case- control study. Mol Biol Rep. 2019; 46(6):6099-6104. DOI: 10.1007/s11033-019-05045-6. View

10.

Tummers B, Green D . Caspase-8: regulating life and death. Immunol Rev. 2017; 277(1):76-89. PMC: 5417704. DOI: 10.1111/imr.12541. View

11.

Mashhadi M, Arbabi N, Sepehri Rad N, Sargazi S, Harati-Sadegh M . Association between common variants in vitamin D receptor gene and susceptibility to Non-Hodgkin's lymphoma: a case-control study. Nucleosides Nucleotides Nucleic Acids. 2021; 40(3):288-299. DOI: 10.1080/15257770.2020.1871488. View

12.

McIlwain D, Berger T, Mak T . Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol. 2015; 7(4). PMC: 4382736. DOI: 10.1101/cshperspect.a026716. View

13.

Xu W, Jiang S, Xu Y, Chen B, Li Y, Zong F . A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility. PLoS One. 2012; 7(5):e37443. PMC: 3355128. DOI: 10.1371/journal.pone.0037443. View

14.

Chun H, Zheng L, Ahmad M, Wang J, Speirs C, Siegel R . Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature. 2002; 419(6905):395-9. DOI: 10.1038/nature01063. View

15.

Harati-Sadegh M, Mohammadoo-Khorasani M, Sargazi S, Saravani R, Shahraki S, Eskandari E . Quantitative Assessment of the Effects of IL-1ß -511 C>T Variant on Breast Cancer Risk: An Updated Meta-Analysis of 3331 Cases and 3609 Controls. Lab Med. 2020; 52(1):36-46. DOI: 10.1093/labmed/lmaa055. View

16.

Yilmaz S, Yencilek F, Yildirim A, Yencilek E, Isbir T . Effects of Caspase 9 Gene Polymorphism in Patients with Prostate Cancer. In Vivo. 2017; 31(2):205-208. PMC: 5411746. DOI: 10.21873/invivo.11046. View

17.

Xie H, Tao W, Wu X, Gu J . Genetic variations in apoptosis pathway and the risk of ovarian cancer. Oncotarget. 2016; 7(35):56737-56745. PMC: 5302949. DOI: 10.18632/oncotarget.10772. View

18.

Wiggins G, Black M, Dunbier A, Merriman T, Pearson J, Walker L . Variable expression quantitative trait loci analysis of breast cancer risk variants. Sci Rep. 2021; 11(1):7192. PMC: 8009949. DOI: 10.1038/s41598-021-86690-5. View

19.

Sargazi S, Saravani R, Zavar Reza J, Zarei Jaliani H, Galavi H, Moudi M . Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells. Iran Biomed J. 2019; 23(5):312-23. PMC: 6661129. View

20.

Liu H, Jiang X, Zhang M, Pan Y, Yu Y, Zhang S . Association of CASP9, CASP10 gene polymorphisms and tea drinking with colorectal cancer risk in the Han Chinese population. J Zhejiang Univ Sci B. 2013; 14(1):47-57. PMC: 3542958. DOI: 10.1631/jzus.B1200218. View